|Articles|July 1, 2007

Pharmacy Times

  • Volume 0
  • 0

Update on Investigational Alzheimer's Drug

Author(s)Susan Farley

Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD). The researchers studying the drug, Memryte, observed positive effects among women but not among men.

The findings have prompted Voyager to focus on developing the drug to treat AD specifically for women.

Articles in this issue

about 19 years ago

pharmacy TECHNOLOGY news

about 19 years ago

pharmacy TECHNOLOGY products

about 19 years ago

health-systems PRODUCT news

about 19 years ago

generic times product news

about 19 years ago

can you READ these Rxs?

about 19 years ago

A closer look at new FDA actions

about 19 years ago

can you READ these Rxs?

about 19 years ago

compounding HOTLINE

about 19 years ago

Is There Science in Quality?

about 19 years ago

Vaccines: Are You Protected?

Latest CME